首页> 外国专利> METHOD OF ESTIMATION OF INFLUENCE OF NITROSAMINES ON APOPTOSIS IN CHILDREN LIVING IN ADVERSE ENVIRONMENTAL CONDITIONS

METHOD OF ESTIMATION OF INFLUENCE OF NITROSAMINES ON APOPTOSIS IN CHILDREN LIVING IN ADVERSE ENVIRONMENTAL CONDITIONS

机译:不良环境条件下亚硝胺对儿童细胞凋亡影响的估算方法

摘要

FIELD: medicine.;SUBSTANCE: blood sample is taken from the child and the presence of nitrosamine-nitroso dimethylamine (NDMA) is determined in the sample, in those blood samples of patients with NDMA, mononuclear cells are extracted and the amount of p53 protein is determined using flow cytometry. A sample of buccal epithelium is also taken from this child and deoxyribonucleic acid (DNA) is extracted from this sample. Then, genotyping of the polymorphism is carried out on the detecting polymerizer using PCR using the Arg72Pro (rs1042522) gene of the TP53 gene as a primer, by examining its allelic state, establishing for the TP53 gene one of the following conditions: heterozygous or normal homozygous or pathological Homozygous. And if the presence of pathological homozygous or heterozygous genotypes of Arg72Pro of the TP53 gene is simultaneously established, a decrease in blood content of p53 in 1.5 and more times, relative to the lower limit of the physiological norm for children. In the presence of NDMA in the blood, the process of apoptosis in a child under the influence of nitrosamines is assessed as delayed.;EFFECT: invention provides an accurate estimate of the effect of nitrosamines on apoptosis with the possibility of subsequently judging the development of immunodeficient and immunoproliferative states of the population already at an early stage.;1 tbl, 2 ex
机译:领域:医学;实体:从儿童那里采集血液样本,并确定其中是否存在亚硝胺-亚硝基二甲基胺(NDMA),在患有NDMA的患者的血液样本中,提取单核细胞并测定p53蛋白的量使用流式细胞仪确定。还从这个孩子那里获取了颊上皮样品,并从该样品中提取了脱氧核糖核酸(DNA)。然后,使用TP53基因的Arg72Pro(rs1042522)基因作为引物,通过PCR检测多聚体的基因型,方法是检查其等位基因状态,确定TP53基因的下列条件之一:杂合或正常纯合子或病理纯合子。而且,如果同时建立了TP53基因Arg72Pro的病理纯合或杂合基因型,则相对于儿童生理正常值的下限而言,p53的血液含量降低了1.5倍以上。在血液中存在NDMA的情况下,评估儿童在亚硝胺的影响下的凋亡过程被延迟。效果:本发明提供了亚硝胺对凋亡的影响的准确估计,并有可能随后判断亚硝胺的发展。人群的免疫缺陷和免疫增生状态已经处于早期阶段; 1 tbl,2 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号